Skip to content

Intrathecal dexmedetomidine alleviates shivering during Cesarean delivery under spinal anesthesia

Intrathecal dexmedetomidine alleviates shivering during Cesarean delivery under spinal anesthesia

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IIR-15007548
Enrollment
Unknown
Registered
2015-12-09
Start date
2015-12-16
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

shivering during Cesarean delivery under spinal anesthesia

Interventions

II:intrathecal dexmedetomidine (DEX) 3 ug

Sponsors

The department of Anesthesiology of the Second Xiangya Hospital of Central South University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: After obtaining approval of the Hospital Ethics Committee at the Second Xiangya Hospital of Central South University, 90 obstetric patients (American Society of Anesthesiologists [ASA] physical status I or II, age range 18 to 40 yr, gestational age >=37 weeks, and singleton pregnancy) scheduled for cesarean delivery under spinal anesthesia with no prior medication history were enrolled in the study.

Exclusion criteria

Exclusion criteria: Parturients with contraindications to regional anesthesia, hypersensitivity to amide local anesthetics or DEX, severe preeclampsia, hyperthyroidism, cardiopulmonary disease, and known history of alcohol or substance abuse were excluded from the study.

Design outcomes

Primary

MeasureTime frame
the incidence of shivering;Severity of shivering;

Secondary

MeasureTime frame
Temperature differential between basic core temperature and shivering threshold temperature;hemodynamics of parturients;Apgar scores;

Countries

China

Contacts

Public ContactXu Junmei
jimyliangdandan@hotmail.com+86 0731-85295973

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026